Hans-Georg Joost

Hans-Georg Joost

Auto-generated profile, based on publicly available information

Hans-Georg Joost

Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, Nuthetal, Germany

Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2013 in Diabetes
Verified
Journal Article
Open access
PDF file
AFAnna Floegel
Anna Floegel
NSNorbert Stefan
Norbert Stefan
ZYZhonghao Yu
Zhonghao Yu
KMKristin Mühlenbruch
Kristin Mühlenbruch
DDDagmar Drogan
Dagmar Drogan
TPTobias Pischon
Tobias Pischon
Metabolomic discovery of biomarkers of type 2 diabetes (T2D) risk may reveal etiological pathways and help to identify individuals at risk for disease. We prospectively investigated the association between serum metabolites measured by targeted metabolomics and risk of T2D in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam (27,548 adults) among all incident cases of T2D (n = 800, mean follow-up 7 years) and a randomly drawn subcohort (n = 2,282). Flow injection analysis tandem mass spectrometry was used to quantify 163 metabolites, including acylcarnitines, amino acids, hexose, and phospholipids, in baseline serum samples. Serum hexose; phenylalanine; and diacyl-phosphatidylcholines C32:1, C36:1, C38:3, and C40:5 were independently associated with increased risk of T2D and serum glycine; sphingomyelin C16:1; acyl-alkyl-phosphatidylcholines C34:3, C40:6, C42:5, C44:4, and C44:5; and lysophosphatidylcholine C18:2 with decreased risk. Variance of the metabolites was largely explained by two metabolite factors with opposing risk associations (factor 1 relative risk in extreme quintiles 0.31 [95% CI 0.21–0.44], factor 2 3.82 [2.64–5.52]). The metabolites significantly improved T2D prediction compared with established risk factors. They were further linked to insulin sensitivity and secretion in the Tübingen Family study and were partly replicated in the independent KORA (Cooperative Health Research in the Region of Augsburg) cohort. The data indicate that metabolic alterations, including sugar metabolites, amino acids, and choline-containing phospholipids, are associated early on with a higher risk of T2D.

25 September 2012 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
Rui Wang-SattlerRui Wang-Sattler
Rui Wang-Sattler
ZYZhonghao Yu
Zhonghao Yu
CHChristian Herder
Christian Herder
AMAna Cristina Messias
Ana Cristina Messias
AFAnna Floegel
Anna Floegel
TIThomas Illig
Thomas Illig
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 January 2001 in Molecular Membrane Biology
Verified
Journal Article
Closed access
HJHans-Georg Joost
Hans-Georg Joost
BTBernard Thorens
Bernard Thorens
During the last 2 years, several novel genes that encode glucose transporter-like proteins have been identified and characterized. Because of their sequence similarity with GLUT1, these genes appear to belong to the family of solute carriers 2A ( SLC2A, protein symbol GLUT). Sequence comparisons of all 13 family members allow the definition of characteristic sugar/polyol transporter signatures: (1) the presence of 12 membrane-spanning helices, (2) seven conserved glycine residues in the helices, (3) several basic and acidic residues at the intracellular surface of the proteins, (4) two conserved tryptophan residues, and (5) two conserved tyrosine residues. On the basis of sequence similarities and characteristic elements, the extended GLUTfamily can be divided intothree subfamilies, namely class I (the previously known glucose transporters GLUT1-4), class II (the previously known fructose transporter GLUT5, the GLUT7, GLUT9 and GLUT11), and class III (GLUT6, 8, 10, 12, and the myoinositol transporter HMIT1). Functional characteristics have been reported for some of the novel GLUTs. Like GLUT1-4, they exhibit a tissue/cell-specific expression (GLUT6, leukocytes, brain; GLUT8, testis, blastocysts, brain, muscle, adipocytes; GLUT9, liver, kidney; GLUT10, liver, pancreas; GLUT11, heart, skeletal muscle). GLUT6 and GLUT8 appear to be regulated by sub-cellular redistribution, because they are targeted to intracellular compartments by dileucine motifs in a dynamin dependent manner. Sugar transport has been reported for GLUT6, 8, and 11; HMIT1 has been shown to be a H + /myo-inositol co-transporter. Thus, the members of the extended GLUT family exhibit a surprisingly diverse substrate specificity, and the definition of sequence elements determining this substrate specificity will require a full functional characterization of all members.

1 September 2004 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
PDF file
ASA Scheepers
A Scheepers
HJHg Joost
Hg Joost
ASAnnette Schürmann
Annette Schürmann

1 November 2007 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
RNRuben Nogueiras
Ruben Nogueiras
PWPetra Wiedmer
Petra Wiedmer
DPDiego Perez-Tilve
Diego Perez-Tilve
CVChristelle Veyrat-Durebex
Christelle Veyrat-Durebex
JKJulia M. Keogh
Julia M. Keogh
MTMatthias H. Tschöp
Matthias H. Tschöp
Disruptions of the melanocortin signaling system have been linked to obesity. We investigated a possible role of the central nervous melanocortin system (CNS-Mcr) in the control of adiposity through effects on nutrient partitioning and cellular lipid metabolism independent of nutrient intake. We report that pharmacological inhibition of melanocortin receptors (Mcr) in rats and genetic disruption of Mc4r in mice directly and potently promoted lipid uptake, triglyceride synthesis, and fat accumulation in white adipose tissue (WAT), while increased CNS-Mcr signaling triggered lipid mobilization. These effects were independent of food intake and preceded changes in adiposity. In addition, decreased CNS-Mcr signaling promoted increased insulin sensitivity and glucose uptake in WAT while decreasing glucose utilization in muscle and brown adipose tissue. Such CNS control of peripheral nutrient partitioning depended on sympathetic nervous system function and was enhanced by synergistic effects on liver triglyceride synthesis. Our findings offer an explanation for enhanced adiposity resulting from decreased melanocortin signaling, even in the absence of hyperphagia, and are consistent with feeding-independent changes in substrate utilization as reflected by respiratory quotient, which is increased with chronic Mcr blockade in rodents and in humans with loss-of-function mutations in MC4R. We also reveal molecular underpinnings for direct control of the CNS-Mcr over lipid metabolism. These results suggest ways to design more efficient pharmacological methods for controlling adiposity.

5 June 2009 in Nature Medicine
Verified
Journal Article
Open access
PDF file
HKHenriette Kirchner
Henriette Kirchner
JGJesus A Gutierrez
Jesus A Gutierrez
PSPatricia J Solenberg
Patricia J Solenberg
PPPaul T Pfluger
Paul T Pfluger
TCTraci A Czyzyk
Traci A Czyzyk
MTMatthias H Tschöp
Matthias H Tschöp
It has been a long-held belief that the hormone ghrelin is activated when an animal is hungry, inducing the brain to increase food intake. Now, Matthias Tschöp and his colleagues show in vivo that it is not the deficiency of calories per se that activates ghrelin, but rather the presence of energy-rich medium-chain dietary fats. Central nervous system nutrient sensing and afferent endocrine signaling have been established as parallel systems communicating metabolic status and energy availability in vertebrates. The only afferent endocrine signal known to require modification with a fatty acid side chain is the orexigenic hormone ghrelin. We find that the ghrelin O-acyl transferase (GOAT), which is essential for ghrelin acylation, is regulated by nutrient availability, depends on specific dietary lipids as acylation substrates and links ingested lipids to energy expenditure and body fat mass. These data implicate the ghrelin-GOAT system as a signaling pathway that alerts the central nervous system to the presence of dietary calories, rather than to their absence as is commonly accepted.